Profound Medical (PROF) vs RxSight, Inc. (RXST)
- Profound Medical PROF 6.01 −4.75%
- RxSight, Inc. RXST 4.51 −3.43%
Profound Medical and RxSight, Inc. are both Medical Devices companies. Profound Medical is the larger, with a market value of $230.5M against $194.2M — 1.2× the size. Profound Medical grew revenue faster over the last twelve months: 61.2% against −13.3%. RxSight, Inc. has the higher net margin (−36.8% vs −171.6%) and the higher return on invested capital (−63.2% vs −137.8%). Across the 18 metrics below, RxSight, Inc. leads on 13 and Profound Medical on 5.
Valuation
Profitability
| Metric | PROF | RXST | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.79% | 77.50% | 56.01% |
| Operating margin | (185.31%) | (43.20%) | (15.03%) |
| Net margin | (171.56%) | (36.80%) | (20.40%) |
| Free cash flow margin | (189.15%) | (21.29%) | (7.24%) |
| Return on equity | (73.53%) | (17.35%) | (15.32%) |
| Return on assets | (58.44%) | (14.19%) | (19.72%) |
| Return on invested capital | (137.78%) | (63.16%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack